Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 2282 filtered startups

Evig Aktiv

EvigAktiv is a mobile app and online platform that provides senior citizens with user-friendly access to all activities within their municipality. EvigAktiv provides municipalities with a standard and affordable solution for announcing activities instead of using ineffective emails, websites, Facebook groups, handwritten notes, and printed ads.

Monio AS

Monio AS (org. nr. 913 978 617) er et heleid datterselskap av SpareBank 1 SR-Bank ASA (org. nr. 937 895 321). Monio AS formidler lån til små og mellomstore bedrifter og er regulert av Finanstilsynet med tillatelse til å drive virksomhet som betalingsforetak og er registrert som låneformidler. Som lånformidler er Monio ikke en part i låneavtalen mellom långiver og låntaker.

Entro

Entro is an energy- and environmental consultancy firm with two clients – our customers and the environment. We save our customers time and money, and we help the environment by reducing energy consumption and carbon footprints. Entro has about 60 employees in Oslo, Trondheim, and Bergen. We had a turnover of NOK 63 million in 2016 and saved our customers NOK 400 million. Entro has a unique interdisciplinary expertise with a good mix of practical and academic skills. Among our staff we have more trade certificates in electrical and construction, more than 60% of the employees are civil engineers and engineers and we have several employees with training in economics and management. We have expertise in electrical, plumbing, building, environment, and IT.

COCO-MAT NORWAY

We sleep on nature. Do you? COCO-MAT er en Internasjonal merkevare representert i 20 land, i mer enn 100 butikker. Du finner oss på over 700 hoteller rundt om i verden, blant annet Athens Sofitel, Landmark Hotel in London, Equinox Hotel i NY, Hidden Hotel in Paris, Ritz-Carlton Barcelona, Hotel De L’Europe Amsterdam og mange flere. Vi har dedikert oss til å produsere verdens beste senger, og de tilvirkes for hånd etter de beste bærekraftige prinsipper. En COCO-MAT madrass består av opp til 14 lag med naturlige materialer som sammen gir optimal og isometrisk støtte til kroppen. Alt uten bruk av metall fjærer, syntetiske stoffer eller annet som naturen ikke enkelt kan resirkulere. Vi skal tilby hoteller og overnattingsteder som tar bærekraft og gjestenes søvn og velvære på alvor de absolutt beste sengene. Vi kan tilby utprøvde konsepter som egen sengemeny og putemeny til utstilling i lobby. Sammen med morselskapet tilbyr vi komplett interiør til hotellrommet. Alle våre produkter er laget av fornybare, naturlige materialer som; kokosnøtt fibre, naturgummi, ull, bomull, kaktus fibre, tang, hestehår, silke, lin, tre og gåsedun. Våre senger er alle laget for hånd på vår egen fabrikk i Xanthi, nord i Hellas. Vi har forpliktet oss til å redusere miljøskadelige utslipp og levere naturlige, helsebringende produkter. Vi forbyr bruken av kjemikalier i eller på våre produkter, og benytter kun økologiske, ufarlige fargestoffer i de tilfellene produktet krever det. COCO-MAT strekker seg langt for å redusere avfall og rest-materialer til et minimum. Ved å investere i nye produksjonsmetoder har vi oppnådd en resirkuleringsgrad på hele 96%. Rester fra produksjonen blir benyttet til å lage andre produkter. Et eksempel på dette er naturgummi fra madrasser, som blir kuttet opp i flak og benyttes som innmat i hodeputer og puter i møbler. COCO-MAT NORSE AS er stiftet i 2017 og er en franchise av COCO-MAT, og representerer merkevaren i Norge.

CardiNor AS

CardiNor AS er et norsk bioteknologiselskap etablert for å håndtere kommersialiseringen av secretoneurin, en ny biomarkør test for hjertekar sykdom. Vår innovasjon er en ny og proprietær hjertekar test – secretoneurin. Secretoneurin er vist å ha sterk prognostisk nytteverdi hos pasienter med hjertesvikt, og den har et særskilt stort potensial hos pasienter med hjerterytmeforstyrrelser (arytmi). Hjertekar sykdom er fortsatt den viktigste dødsårsaken i verden i dag. Ingen av de kjent og etablerte biomarkørene for hjertekar sykdom er til særlig hjelp i valg av medisinske, og eller kirurgiske behandlingsmetoder for å forhindre livstruende hjerterytmeforstyrrelser. Selskapet utvikler nå en brukervennlig forskningstest for å måle secretoneurin blod som vil markedsført og solgt gjennom et nettverk av distributører i Europa og USA. Dette etterfulgt av introduksjonen av et CE-merket produkt for klinisk bruk i Europa og regulatorisk godkjenning i USA. CardiNor-ledelsen har inngående kunnskap om og erfaring fra bioteknologi og diagnostisk industri som dekker hele livssyklus fra oppstart til exit. CardiNor samarbeider med verdensledende akademiske institusjoner og opinionsledere og industri i å utvikle og dokumentere biomarkør testen.

Biozep AS

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

Pharmasum Therapeutics AS

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Nordic Electrofuel

Nordic Electrofuel offers a solution for the rapid transition from fossil to renewable electrical energy for all transport sectors. It is based on the conversion of renewable electric energy into liquid electro-fuels that can be as easily transported, stored, and used as conventional fossil hydrocarbons. It also provides a good solution to distribute and store stranded electrical energy. PTL (Power To Liquid) has been considered too expensive, but with the low electricity price in Norway and new efficient processing and upgrading solutions, it has become commercially feasible. Electrification of transportation is required to avoid catastrophic climate change. Battery- or cable-electric solutions are not feasible for transport like aviation and long-distance marine transport. Liquid energy carriers such as biofuels are desperately needed but limited. The fuel is free of sulfur and can therefore be used maritime industry as a fuel after 2022. The fuel emits much fewer particles and aromatics than conventional fossil fuel, so it also solves the local pollution problem. Competitive advantages: • Norway’s low electricity price from hydro and lately also wind power. • 20 - 30 % lower electricity consumption than with existing technology • Lower production price than advanced biofuels • Agreements in place for a site at Herøya, which has all utilities (cooling water, cheap renewable electricity, etc.) and processing expertise available. • About the same source to shaft efficiency as hydrogen, but with much lower total CAPEX due to no investment in distribution systems and engines.

Mana Communication AS

Markedsavdeling til utleie- Kommunikasjons- /PR- byrå med høy ekspertise innenfor digital markedsføring. Vi leier ut våre tjenester og fungerer for mange av våre kunder som bedfriftens egen markedsavdeling. Vi er også inne som strategisk rådgiver i større bedrifter som mangler spisskompetanse på sosiale medier, PR/krisehåndtering, annonsering og digital synlighet. Innsikt er nøkkelen for å lykkes, og vi har derfor tilgang på de beste analyseverktøy, og skreddersyr digitale markedsstrategier. VI SER NÅ PÅ MULIGHETEN TIL Å UTVIKLE ET HELT NYTT SYSTEM SOM MARKEDET HAR STORT BEHOV FOR. VI ØNSKER I DEN FORBINDELSE KONTAKT MED INVESTORER. Våre tjenester inkluder idag: Sosiale medier - drift og strategi Foto og video( herunder Cinematics, timelaps, animasjon, drone etc) Web/ SEO Innholdsproduksjon og artikler Analyse Digital mediestrategi PR og kampanjeplanlegging Pressemeldinger inkl. utsendelse Rådgiving og koordinator på store prosjekter Design og utarbeidelse av annonser, magasiner og Power Point-presentasjoner. Vi bygger merkevarekunnskap og øker lojalitet gjennom korrekt kommunikasjon i de medier kunden befinner seg, og innenfor tidsrammen hvor kundene er lydhøre for budskap. Kort oppsummert - Vi skaper engasjement for din merkevare i digitale kanaler.

Nordic Data Resources AS

Nordic Data Resources is a leading online data provider, well established in all the Nordic markets after a successful market launch in Q4 2015. We have run more than 1000 campaigns with 100 media agencies in our first 18 months, which generated revenue of € 0,5 million in 2016. We have a monthly run rate of more than € 100 k, which will increase significantly moving forward, particularly when we have globally launched our data. 1) PRODUCT We have developed a scalable, full-reach consumer classification online audience data suite, available for any programmatic platform and digital channel. We specialize in geo-targeting and consumer classification data to reach the entire population. Our data provide a unique way of targeting audiences in a safe and reliable way, available for both buy-side and sell-side, as well as data exchanges and DMPs. Please look at our video presenting the consumer classification audience data; https://vimeo.com/193398498. 2) REVENUE MODEL We distribute our data through programmatic trading platforms and data exchanges to advertisers/agencies (buy-side) and publishers (sell-side). Our revenue is driven by ad impressions using our data to target more effectively. We offer CPM based pricing model in the programmatic platforms, as well as a monthly fixed DMP agreement (recurring revenue model) 3) STRONG MARKET GROWTH / CUSTOMERS The data market is driven by the strong growth in the programmatic buying of ads on the internet, mobile, and soon TV. It’s the best-performing sector in the ad industry (40% growth in 2016). Our market is both the media buyer and the publishers; Agency customers / buy-side We have run more than 1000 campaigns with 100 agencies and all of the global media agency groups in the Nordic countries. See more about our Buy Side offering; http://nordicdataresources.com/agencies/ Publisher customers / sell side We launched our audiences in the Publisher market in Q1 and are now starting up with leading Nordic publishers, both broadcasters and online publishers. See more; http://nordicdataresources.com/publishers/ 4) GLOBAL PARTNERSHIPS We work closely with global players in the online data /programmatic advertising industry, who have established platforms, infrastructure, and customer bases, which helps us to scale our business. We have focused on this since we started and have many great partners like Oracle, MediaMath, Google, Experian, Adform, Semasio, InsightOne, Digital Element, and son. You can see more on http://nordicdataresources.com/platforms/ 5) SCALABLE BUSINESS MODEL Data is the new gold on the internet and represents a strong growth area, growing together with programmatic trading's 30-40% market share. It is predicted that programmatic buying and selling will soon and completely take over the ad market. We have built a global distribution from day one with the leading data exchanges and programmatic trading platforms, so we have a very scalable business and revenue model. We have successfully launched our data in the Nordic markets and are now launched in Germany. Nordic Data Resources has an international "Go to Market" strategy where we plan to globally launch our data in the next 3-9 months. We are able to do this since we have a global audience data set and distribution partners, the key job is to make trading desks and media agencies aware of the existence and great value. As soon as they have tested the data, they can measure their performance, which drives the use of more data. 6) EXPERIENCED  FOUNDER/MANAGEMENT TEAM We are a founding team of 19 internet veterans, and all of us have long internet and online advertising experience. See http://nordicdataresources.com/about/ for the team overview. All in all, the founding team has a total of 150 years of Internet/advertising/data background;

Lima Regnskap AS

Lima Regnskap AS er et autorisert regnskapsførerselskap som utfører alt innen regnskap, lønn, konsulentbistand, årsavslutning og har erfaring innen de fleste bransjer. Videre bistår vi gjerne med oppstart og registrering av nye virksomheter. Regnskapsfirmaet startet opp 1 juli 2017. Kontoret har en sentral beliggenhet på Ålgård.

Octaos AS

Octaos is an IT development company, creating modern web-based products to support the processes of the building industry. We make online graphical product configurators fully integrated with the manufactures ERP-systems, for use in both for the professional and the consumer market. Today we have customers in Norway, Sweden and in the UK, - and we have plans to soon grow beyond these business areas.

Biofood Trade AS

We start our project in 2017. We develop and offer to the market ecological & sustainable fertilizers made by mineral and organic nature. We cultivate a unique product and engage experience and innovation. By offering a quality product with added value to our customers, we help make a cost-effective solution for horticulture and agriculture.  We are happy to be engaged in the optimization of performance for allied businesses and private customers.

Metra Næringsmegling AS

Som megler kan du ikke sitte et helt annet sted og tro at du kjenner Østfold og Follo. Du må være der! Vite hva som rører seg. Kjenne pulsen og identiteten til de ulike stedene i distriktet. Ha oversikt over utbyggingsplaner, reguleringer og ikke minst preferanser i markedet.Derfor bør det være ditt førstevalg å kontakte en megler som holder til i regionen. Metra Næringsmegling er den største næringsmegleren i området. Vi har årelang erfaring, mye detaljkunnskap og avdelinger både i Moss og Fredrikstad og i 2016 åpner vi kontor i Ski. Og det beste av alt er at vi er mye mer enn en megler. Vi kan bistå deg og din bedrift med forvaltning, økonomistyring, verdivurderinger, analyser og rådgivning i tilknytning til eiendomsutvikling. Mer info på vår hjemmeside: www.metra.no

Smak av Italia

Smak av Italia har tre avdelinger i henholdsvis Sætre, Slemmestad og Oslo (Vulkan). Alle tre butikkene selger de samme økologiske, ekte og naturlige varene fra produsenter i Italia. I butikkene våre finner du alltid smaksprøver slik at alle har anledning til å smake på de nøye utvalgte varene. Vi ønsker at våre produkter skal bidra til gode måltider, både i hverdagen og til fest med rene, sunne og enkle retter. Alle varene vi selger er uten tilsetningsstoffer og produsert på en gammeldags, tradisjonell måte for å bevare det naturlige og rene. Vi er opptatt av god service og vil hjelpe til så mye vi kan! Har du spørsmål angående våre produkter, leverandører eller oppskrifter er vi alltid tilgjengelige.